{"id":"W4401219535","doi":"10.3899/jrheum.2024-0298","title":"Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study","year":2024,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation","funders":"H2020 European Research Council; EMD Serono; Idorsia Pharmaceuticals; Swedish Orphan Biovitrum; Österreichische Forschungsförderungsgesellschaft; F. Hoffmann-La Roche; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Celgene; Biogen; Sanofi; Austrian Science Fund; Amgen; Pfizer; Janssen Research and Development; OPKO Health; Eli Lilly and Company; AstraZeneca; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Golimumab; Juvenile; Arthritis; Open label; Juvenile rheumatoid arthritis; Term (time); Internal medicine; Pediatrics; Surgery; Dermatology; Adalimumab; Clinical trial; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002265,0.0001767745,0.0010632,0.0002856712,0.0000859577,0.00003827831,0.0004652847,0.00009423587,0.00007774481],"category_scores_gemma":[0.00008507776,0.0001062675,0.00004584869,0.0003509951,0.0002354996,0.0003125333,0.0001398844,0.0007732342,0.00001225102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005186199,"about_ca_system_score_gemma":0.0008386357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003933013,"about_ca_topic_score_gemma":0.000298759,"domain_scores_codex":[0.9974691,0.0004686481,0.001122772,0.0001847747,0.0004201515,0.0003346131],"domain_scores_gemma":[0.9987884,0.00006482216,0.000365345,0.0004589205,0.0002030998,0.0001194828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02180701,0.03089235,0.6626005,0.0004602492,0.002584506,0.005874016,0.02018136,0.00009162146,0.018768,0.0003286512,0.0003063598,0.2361054],"study_design_scores_gemma":[0.1059783,0.05387806,0.6624385,0.007081769,0.0009478088,0.1570953,0.008037958,0.001563526,0.002155345,0.0003277027,0.0000229181,0.0004728783],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801517,0.01821714,0.0001067585,0.0005353177,0.00009144921,0.0008588143,0.000002049021,0.00001528107,0.0000214882],"genre_scores_gemma":[0.9980381,0.001800226,0.00003629979,0.0000390927,0.00001165793,0.000009463804,0.00000365809,0.00003461019,0.00002696401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2356325,"threshold_uncertainty_score":0.4333461,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02007188285523857,"score_gpt":0.3334249473702102,"score_spread":0.3133530645149716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}